Jill Wechsler

Article

Jill Wechsler
Washington editor
Washington Report
jwechsler@advanstar.com

Jill Wechsler is a veteran Washington reporter specializing in government policies that affect biomedical research and development and health care delivery in the US and abroad. She regularly writes about the Food and Drug Administration, Congress and federal and state policies as Washington editor of Pharmaceutical Executive, Pharmaceutical Technology, Applied Clinical Trials, BioPharm International and Managed Healthcare Executive magazines - all published by Advanstar Communications. In her career as a writer and editor she has contributed to a number of national consumer and specialized publications including Money Magazine, The Washington Post, Working Woman, American Artist, Dun's Review, and Good Housekeeping.

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content